Home
News
New Pfizer product given FDA approval
The FDA recently approved new EXCENEL® RTU EZ
(ceftiofur hydrochloride) Sterile Suspension to treat and control metritis,
bovine and swine respiratory disease and foot rot.
With easy administration, EXCENEL RTU EZ supplies
producers with the same efficacy as EXCENEL RTU in a tissue-friendly, low-volume
dose. The new formulation, available in 100 mL vials and featuring a new yellow
skirt colour, adds flexibility to management and treatment programs due to the
easier syringeability and ready-to-use packaging, flexible dosing and short,
pre-slaughter withdrawal.
In swine, EXCENEL RTU EZ has been approved for
the treatment and control of the major causes of swine respiratory disease in
growing and finishing pigs. Its improved formulation makes intramuscular
injections easier for user convenience and effectively kills bacteria with no
appreciable change in susceptibility in targeted swine pathogens.
This
fast-acting formula covers the entire treatment interval until the next
administration. EXCENEL RTU EZ is a great anti-infective option in the late
finishing stage because it provides quick absorption in tissue and a short
four-day pre-slaughter withdrawal time.
EXCENEL RTU EZ establishes
therapeutic concentrations in as little as one hour to effectively treat a broad
spectrum of pathogens that cause bacterial respiratory disease in swine;
metritis, shipping fever, pneumonia and foot rot in dairy cows; and bovine
respiratory disease in cattle.
EXCENEL RTU EZ should be administered
subcutaneously (cattle) or intramuscularly (swine) and requires no refrigeration
or reconstitution. The product can be administered daily or every other day in
cattle and should be administered daily for three consecutive days in swine.
Related Website
•
Pfizer
Subscribe here to the Pig Progress
newsletter
Editor PigProgress
To comment, login here
Or register to be able to comment.